#79 — Michael Dustin is a Kennedy Trust Professor of Molecular Immunology and Director of Research at the Kennedy Institute of Rheumatology at the University of Oxford. In this episode of The Microscopists, Michael joins Peter O’Toole to discuss how changing the way you pitch grant applications influences how well they are received and how antibodies got their naming convention. They also chat about patent funding and networking through social media.

Watch or listen to all episodes of The Microscopists: http://themicroscopists.bitesizebio.com/